Articles by Philip Ward - Applied Clinical Trials


Articles by Philip Ward

Philip Ward

Philip Ward is ACT's European editor, phone +44 1244 538583,

ESMO Voices Deep Concern About Future of Cancer Research
July 25, 2014

ESMO is concerned that the proposed European Union General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.

EMA Issues Robust Response to Conflict of Interest Claims
July 17, 2014

EMA has insisted that the concerns raised about its scientific advice given to pharmaceutical companies stem from a flawed understanding of the activities of the agency and its partners in this area.

Is it Time to Lock up those who Commit Research Fraud?
July 16, 2014

Two experts have engaged in a lively debate about whether research fraud should be classed as a criminal act.

French Legislation Comes in for Strong Criticism
July 10, 2014

The French government's intention to broadly enlarge the use of off-label drugs for economic reasons is wrong, according to a statement issued by EFPIA

EMA Delays Decision on Clinical Trial Data until October
July 10, 2014

EMA has postponed formal adoption of the policy on publication of clinical trial data until its October 2, 2014 meeting

EFPIA Unveils Action Plan for Lithuania
July 10, 2014

The Lithuanian Ministry of Health and EFPIA have announced a new Joint Working Agreement.

European Regulators Collaborate on Health Technology Assessment
June 27, 2014

The report of a joint initiative by the EMA and the EUnetHTA has been published.

England Reaches New Recruitment Landmark for Clinical Research
June 27, 2014

More than three million National Health Service patients in England have participated in research studies over the last six years.

UK Issues New Guidance on Pediatric Trials
June 25, 2014

Children and young people should routinely be offered the opportunity to participate in and to benefit from medical research.



Untitled Document
Click here